Document Detail


Alpha 1- and alpha 2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo.
MedLine Citation:
PMID:  6209507     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The role of alpha-adrenoceptor subtypes mediating vasoconstriction of large epicardial and small resistive coronary arteries was investigated in 26 open-chest dogs. The left circumflex coronary artery was perfused at a constant pressure. Large vessel vasomotion was determined by measurement of circumflex coronary arterial diameter (ultrasonic transit-time technique); the vasomotion of the small resistive coronary arteries was determined from calculated end-diastolic circumflex artery resistance. beta-Receptors were blocked by propranolol (2 mg/kg i.v.) and both vagal nerves were cut. In eight dogs, the intracoronary administration of the alpha 1-adrenoceptor agonist methoxamine (500 micrograms) increased calculated large vessel resistance by 18.8 +/- 5.7% and end-diastolic resistance by 9.5 +/- 0.3%. Intracoronary administration of the alpha 2-adrenoceptor agonist BHT 920 (500 micrograms) did not affect large vessel resistance, but increased end-diastolic resistance by 37.5 +/- 5.6%. In an additional 18 dogs, left cardiac sympathetic nerve stimulation induced an increase in large vessel resistance by 11.1 +/- 0.9% and in end-diastolic resistance by 31.8 +/- 3.0%. The increase in large vessel resistance was prevented by the alpha 1-adrenoceptor antagonist prazosin (1.2 mg/kg i.v.), which still permitted an increase in end-diastolic resistance by 23.0 +/- 3.2%. The increase in end-diastolic resistance was prevented by the alpha 2-adrenoceptor antagonist rauwolscine (0.2 mg/kg i.v.), which still permitted an increase in large vessel resistance by 11.9 +/- 2.4%. The calcium antagonist nifedipine (20 micrograms/kg i.v.) prevented both the increase in large vessel resistance and end-diastolic resistance during sympathetic stimulation.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
G Heusch; A Deussen; J Schipke; V Thämer
Related Documents :
18698147 - Improved metabolic control results in better myogenic response of retinal arterioles in...
2553897 - Functional aspects of myogenic vascular control.
7710347 - The ability of laparoscopic clips to withstand high intraluminal pressure.
12168287 - Cyclic variation of cerebral pial arteriolar diameter synchronized with positive-pressu...
775627 - Pulmonary vein flow pattern in man during thoracotomy.
21505107 - Rapid development of infusion-related severe hypotension during rituximab therapy (may).
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  6     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:    1984 Sep-Oct
Date Detail:
Created Date:  1984-12-28     Completed Date:  1984-12-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  961-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Azepines / pharmacology
Coronary Vessels / drug effects,  physiology*
Dogs
Electric Stimulation
Heart / innervation
Methoxamine / pharmacology
Nifedipine / pharmacology
Prazosin / pharmacology
Receptors, Adrenergic, alpha / physiology*
Sympathetic Nervous System / physiology
Vasoconstriction* / drug effects
Chemical
Reg. No./Substance:
0/Azepines; 0/Receptors, Adrenergic, alpha; 19216-56-9/Prazosin; 21829-25-4/Nifedipine; 36085-73-1/talipexole; 390-28-3/Methoxamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Changes in blood pressure and plasma catecholamines caused by tyramine and cold exposure.
Next Document:  Thromboxane synthetase inhibitor UK38,485 lowers blood pressure in the adult spontaneously hypertens...